We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:ZVRA
​
​
logo

Zevra Therapeutics (ZVRA)

Nasdaq • ZVRA • US4884452065

11.61Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 12.4% of free float sold short, 7.8 days to cover, cost to borrow 0.39%. Sign up for live short interest data.

Market Cap

691m USD | # 5536 in US

Volume

893.65k shares | 10.01m USD

Shares Outstanding

59.5m

Free Float Shares

90.74% | 53.99m

DB:1GDA

News

ZVRA key data

Zevra Therapeutics (Nasdaq: ZVRA) has a market capitalization of $690.85M. Last close $11.61 (as of 2026-11-09); 52-week range $8.01 to $15.04. ORTEX data as of 2026-10-22: short interest was 12.44% of free float, 7.8 days to cover and the average cost to borrow was 0.39%. Sign up for live short interest data.

  • ZVRA news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.